IL-17 in chronic obstructive pulmonary disease

References

• Palmer MT, Weaver CT. Autoimmunity: increasing suspects in the CD4+ T cell lineup. Nat. Immunol.11, 36–40 (2010).
   PubMed Web of Science ®Google Scholar
• Dubin PJ, Kolls JK. Th17 cytokines and mucosal immunity. Immunol. Rev.226, 160–171 (2008).
   PubMed Web of Science ®Google Scholar
• Mangan PR, Harrington LE, O’Quinn DB. Transforming growth factor-β induces development of the TH17 lineage. Nature441, 231–234 (2006).
   PubMed Web of Science ®Google Scholar
• Mak JC, Chan-Yeung MM, Ho SP et al. Elevated plasma TGF-β1 levels in patients with chronic obstructive pulmonary disease. Respir. Med.103, 1083–1089 (2009).
   PubMed Web of Science ®Google Scholar
• Perera WR, Hurst JR, Wilkinson TM et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur. Respir. J.29, 527–534 (2007).
   PubMed Web of Science ®Google Scholar
• Vargas-Rojas MI, Ramírez-Venegas A, Limón-Camacho L, Ochoa L, Hernández-Zenteno R, Sansores RH. Increase of Th17 cells in peripheral blood of patients with chronic obstructive pulmonary disease. Respir. Med.105, 1648–1554 (2011).
   PubMed Web of Science ®Google Scholar
• Jones CE, Chan K. Interleukin-17 stimulates the expression of interleukin-8, growth-related oncogene-α, and granulocyte-colony-stimulating factor by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol.26, 748–753 (2002).
   PubMed Web of Science ®Google Scholar
• Burgler S, Ouaked N, Bassin C et al. Differentiation and functional analysis of human TH17 cells. J. Allergy Clin. Immunol.123, 588–595 (2009).
   PubMed Web of Science ®Google Scholar
• Steinman L. A brief history of TH17, the first major revision in the TH1/TH2 hypothesis of T cell-mediated tissue damage. Nat. Med.13, 139–145 (2007).
   PubMed Web of Science ®Google Scholar
• Harrison OJ, Foley J, Bolognese BJ, Long E 3rd, Podolin PL, Walsh PT. Airway infiltration of CD4+ CCR6+ Th17 type cells associated with chronic cigarette smoke induced airspace enlargement. Immunol. Lett.121, 13–21 (2008).
   PubMed Web of Science ®Google Scholar
• Shan M, Cheng HF, Song LZ et al. Lung myeloid dendritic cells coordinately induce Th1 and Th17 responses in human emphysema. Sci. Transl. Med.1, 4–10 (2009).
   Google Scholar
• Michel ML, Keller AC, Paget C et al. Identification of an IL-17-producing NK1.1(neg) iNKT cell population involved in airway neutrophilia. J. Exp. Med.204, 995–1001 (2007).
   PubMed Web of Science ®Google Scholar
• Happel KI, Zheng M, Young E et al. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol.170, 4432–4436 (2003).
   PubMed Web of Science ®Google Scholar
• Takatori H, Kanno Y, Watford WT et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med.206, 35–41 (2009).
   PubMed Web of Science ®Google Scholar
• Hamada H, Garcia-Hernandez Mde L, Reome JB et al. Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J. Immunol.182, 3469–3481 (2009).
   PubMed Web of Science ®Google Scholar
• Shibata K, Yamada H, Nakamura R, Sun X, Itsumi M, Yoshikai Y. Identification of CD25+ γδ T cells as fetal thymus-derived naturally occurring IL-17 producers. J. Immunol.181, 5940–5947 (2008).
   PubMed Web of Science ®Google Scholar
• Bettelli E, Korn T, Kuchroo VK. Th17: the third member of the effector T cell trilogy. Curr. Opin. Immunol.19, 652–657 (2007).
   PubMed Web of Science ®Google Scholar
• Lindén A, Laan M, Anderson GP. Neutrophils, interleukin-17A and lung disease. Eur. Respir. J.25, 159–172 (2005).
   PubMed Web of Science ®Google Scholar
• Miossec P, Korn T, Kuchroo VK. Interleukin-17 and Type 17 helper T cells. N. Engl. J. Med.361, 888–898 (2009).
   PubMed Web of Science ®Google Scholar
• Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology129, 311–321 (2010).
   PubMed Web of Science ®Google Scholar
• Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity21, 467–476 (2004).
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J. Leukocyte Biol.71, 1–8 (2002).
   PubMed Web of Science ®Google Scholar
• Wright JF, Guo Y, Quazi A et al. Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells. J. Biol. Chem.282, 13447–13455 (2007).
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Caramori G, Gnemmi I et al. T helper Type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin. Exp. Immunol.157, 316–324 (2009).
   PubMed Web of Science ®Google Scholar
• Eustace A, Smyth LJ, Mitchell L, Williamson K, Plumb J, Singh D. Identification of cells expressing interleukin-17A and F in the lungs of COPD patients. Chest139, 1089–1100 (2011).
   PubMed Web of Science ®Google Scholar
• Chang Y, Nadigel J, Boulais N et al. CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease. Respir. Res.12, 43 (2011).
   PubMed Web of Science ®Google Scholar
• Rahman MS, Yang J, Shan LY et al. IL-17R activation of human airway smooth muscle cells induces CXCL-8 production via a transcriptional-dependent mechanism. Clin. Immunol.115, 268–276 (2005).
   PubMed Web of Science ®Google Scholar
• Hong SC, Lee SH. Role of Th17 cell and autoimmunity in chronic obstructive pulmonary disease. Immune. Netw.10, 109–114 (2010).
   PubMedGoogle Scholar
• Vanaudenaerde BM, Verleden SE, Vos R et al. Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders. Am. J. Respir. Crit. Care Med.183, 977–986 (2011).
   PubMed Web of Science ®Google Scholar
• Doe C, Bafadhel M, Siddiqui S et al. Expression of the T helper 17-associated cytokines IL-17A and IL-17F in asthma and COPD. Chest138, 1140–1147 (2010).
   PubMed Web of Science ®Google Scholar
• Shen N, Wang J, Zhao M, Pei F, He B. Anti-interleukin-17 antibodies attenuate airway inflammation in tobacco-smoke-exposed mice. Inhal. Toxicol.23, 212–218 (2011).
   PubMed Web of Science ®Google Scholar
• McKinley L, Alcorn JF, Peterson A et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol.181, 4089–4097 (2008).
   PubMed Web of Science ®Google Scholar
• Ghannam S, Pene J, Torcy-Moquet G, Jorgensen C, Yssel H. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J. Immunol.185, 302–312 (2010).
   PubMed Web of Science ®Google Scholar
• Smolen JS, Beaulieu A, Rubbert-Roth A et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet371, 987–997 (2008).
   PubMed Web of Science ®Google Scholar
• Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJ. The safety and side effects of monoclonal antibodies. Nat. Rev. Drug Discov.9, 325–338 (2010).
   PubMed Web of Science ®Google Scholar